Abivax Stock News & Updates
[WKN: A14UQC | Symbol: 2X1]
Abivax: Biotech Hope with Strong Seasonal Tailwind
Abivax is a French-American biotech company developing drugs for chronic inflammatory diseases. At the...
Abivax S.A.: Results of the ABTECT Study Part 2 Trigger 36% Share Price Increase - Is This the Starting Shot for a Bigger Move?
Positive data for Obefazimod in hard-to-treat ulcerative colitis demonstrate sustained efficacy. The...
US Markets Little Changed Ahead of Interest Rate Decision - SpaceX Plans IPO - Oracle Reports After-Hours Numbers - Silver Reaches Record High - DAX Just Above 24,000 Points - Abivax Rises on Acquisition Rumors - EchoStar Benefits from SpaceX Speculation - Palantir Wins Major Contract from US Military
US Markets Little Changed - Investors Await Interest Rate Decision The stock markets are treading...
Abivax S.A.: Share Price Multiplier Effect Following Phase 3 Study Data for Obefazimod - Experts React With Enormous Price Target Increases!
Abivax achieved a significant milestone on July 22 with the announcement of positive Phase 3 results...
Analysts' Top 5 Price Targets of July 23, 2025
BioMarin Pharmaceuticals [US09061G1013] Leerink Partners reaffirms Buy rating with a price target...
- ‹
- 1
- ›